A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
Conditions:   Polymyositis;   Dermatomyositis Interventions:   Drug: Ustekinumab 6 mg/kg;   Drug: Ustekinumab 90 mg;   Drug: Placebo IV;   Drug: Placebo SC Sponsor:   Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2019 Category: Research Source Type: clinical trials

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Conditions:   SCAD;   Addison Disease;   Ankylosing Spondylitis;   Antiphospholipid Antibody Syndrome;   Celiac Disease;   Crohn Disease;   Dermatomyositis;   Polymyositis;   Guillain-Barre Syndrome;   Hepatitis, Autoimmune;   Graves Disease;   Hashimoto Thyroiditis;   Multiple Sclerosi s;   Myasthenia Gravis;   Pernicious Anemia;   Polymyalgia Rheumatica;   Primary Biliary Cirrhosis;   Psoriasis;   Rheumatoid Arthritis;   Systemic Sclerosis;   Sjögren Syndrome;   Systemic Lupus Erythematosus;   Takayasu Arteritis;   Type 1 Diabetes Mellitus;   Ulcerative  Colitis;   Uve...
Source: ClinicalTrials.gov - May 7, 2019 Category: Research Source Type: clinical trials